8-KThe WireRoutine
Shareholder Vote
Filed Jun 6, 2023 · 3y ago · Accession 0001664710-23-000036
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Keros Therapeutics, Inc.
- Ticker
- KROS
- CIK
- 1664710
- Form type
- 8-K
- Filing date
- Jun 6, 2023
- Report date
- Jun 6, 2023
- Document
- kros-20230606.htm
- Size
- 191 KB